Paper4127547
Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay.
Gordon YB and 3 others. Lancet, 1973. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay. Papers, record 4127547. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4127547
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrinogen | Major topic |
| Radioimmunoassay | Major topic |
| Animals | |
| Antibody Formation | |
| Blood Coagulation | |
| Fibrin | |
| Fibrinolysin | |
| Hemagglutination Inhibition Tests | |
| Humans | |
| Rabbits |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7359154 | Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding? | J Neurol Neurosurg Psychiatry | 1980 | https://conductscience.org/library/papers/7359154 | PubMed |
| 6654954 | Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusions of patients with malignant disease. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6654954 | PubMed |
| 6497463 | Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity. | Ann Rheum Dis | 1984 | https://conductscience.org/library/papers/6497463 | PubMed |
| 1197151 | Monitoring the fetoplacental unit. The placenta. | Postgrad Med J | 1975 | https://conductscience.org/library/papers/1197151 | PubMed |
| 932225 | Conditions for collection of serum samples for the measurement of fibrin(ogen) degradation products by radioimmunoassay of fragment E. | J Clin Pathol | 1976 | https://conductscience.org/library/papers/932225 | PubMed |
| 803853 | Urinary fibrin-fibrinogen degradation products in nephrotic syndrome. | Br Med J | 1975 | https://conductscience.org/library/papers/803853 | PubMed |
| 346153 | Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? | Br Med J | 1978 | https://conductscience.org/library/papers/346153 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4127547
GET https://conductscience.org/api/papers/v1/4127547/authors